Munger Mode rating: 2 out of 5 — Sell. Our own rating from the research report below, on business quality first: moat durability and management, with price separating the top three.
Authors: Warren Buffett & Charlie Munger MetLife is one of the largest life insurers in the world, with $743 billion of assets, six operating segments, and a recently expanded asset-management arm (MIM). It is a perfectly competent enterprise run by competent people. It is also, in our considered judgment, a fundamentally average business — and average businesses, regardless of price, do not warrant the deployment of permanent capital when there are wonderful businesses available in the market. We rate MET ★★ (Sell), not because anything is broken, but because nothing about its underlying economics suggests it will compound shareholder capital at a rate worth the patience. The current share price hovers in the $83–$86 range (~$84.50 mid-point, May 8, 2026), implying a market capitalization of roughly $54 billion against ~643 million shares outstanding.
Recent filings analysed: 10-Q (2026-08-06), 8-K (2026-08-05), 8-K (2026-06-29), 8-K (2026-06-22).
Stock screener · Superinvestor 13F holdings · Analyst sentiment · Market valuation